Evidence map›Paper›PMID 29231124›Full record

ArticleCell cycle (Georgetown, Tex.)2018

Unraveling Neuroblastoma Pathogenesis with the Zebrafish.

Erin N Dankert, A Thomas Look, Shizhen Zhu

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Metastasis in neuroblastoma: theFrontiers in oncology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Erin N Dankerta Department of Biochemistry and Molecular Biology , Mayo Clinic College of Medicine, Mayo Clinic Cancer Center , Rochester , MN , USA.
A Thomas Lookb Department of Pediatric Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
Shizhen Zhua Department of Biochemistry and Molecular Biology , Mayo Clinic College of Medicine, Mayo Clinic Cancer Center , Rochester , MN , USA.

Funding

Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk NeuroblastomaR00CA178189 · NCI · MAYO CLINIC ROCHESTER · PI ZHU, SHIZHEN · 2015 to 2017
$747k
Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk NeuroblastomaK99CA178189 · NCI · MAYO CLINIC ROCHESTER · PI ZHU, SHIZHEN · 2013 to 2014
$245k
NCI NIH HHS K99 CA178189NCI NIH HHS R00 CA178189
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeuroblastomaZebrafishAnimalsN-Myc Proto-Oncogene ProteinN-Myc Proto-Oncogene ProteinGWASLMO1metastasisMYCNNeuroblastomatumorigenesiszebrafish model

Identifiers

PMID29231124
PMCPMC5927653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.